BRD4-TARGETED THERAPY ABBV-744 CLINICAL DATA NO FURTHER A MYSTERY

In Phase A, individuals will receive different doses and schedules of oral ABBV-744 pill to discover Risk-free dosing regimen. Additional individuals will likely be enrolled in the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 are going to be specified as "include-on" therapy. In Phase C, indi